Tablet

Nabriva Therapeutics to Present Data at CHEST Annual Meeting 2021

Friday, October 15, 2021 - 9:05pm

DUBLIN, Ireland and FORT WASHINGTON, Pa., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today, announced data presentation at CHEST 2021, the annual meeting of the American College of CHEST Physicians, which will be held virtually October 17-20.

Key Points: 
  • DUBLIN, Ireland and FORT WASHINGTON, Pa., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today, announced data presentation at CHEST 2021, the annual meeting of the American College of CHEST Physicians, which will be held virtually October 17-20.
  • Nabriva Therapeutics is also developing CONTEPO (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis.
  • In addition, the forward-looking statements included in this press release represent Nabriva Therapeutics views as of the date of this press release.
  • These forward-looking statements should not be relied upon as representing Nabriva Therapeutics views as of any date subsequent to the date of this press release.

Information Update - UPDATE: Auro Pharma Inc., Pharmascience Inc. and Sivem Pharmaceuticals ULC recall multiple lots of losartan

Friday, October 15, 2021 - 8:30pm

OTTAWA, ON, Oct. 15, 2021 /CNW/ -Auro Pharma Inc., Pharmascience Inc., and Sivem Pharmaceuticals ULC are recalling multiple lots of prescription losartan tablets, in 25 mg, 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole)above the acceptable limit.

Key Points: 
  • OTTAWA, ON, Oct. 15, 2021 /CNW/ -Auro Pharma Inc., Pharmascience Inc., and Sivem Pharmaceuticals ULC are recalling multiple lots of prescription losartan tablets, in 25 mg, 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)-1H tetrazole)above the acceptable limit.
  • Long-term exposure to the impurity at levels above what is considered safe could potentially increase the risk of cancer.
  • Please see the full advisory for more information, including what Canadians should do and Health Canada's work to address the issue of azido impurities found in certain drugs.

Global IoT Connectivity Market Analysis and Forecast Report 2021 - ResearchAndMarkets.com

Friday, October 15, 2021 - 2:21pm

The "Global IoT Connectivity Market Report and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global IoT Connectivity Market Report and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global IoT connectivity market attained a value of about USD 163.2 billion in 2020.
  • The IoT connectivity market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 20.9% to reach approximately USD 493 billion by 2026.
  • The IoT connectivity market is being driven by the rising demand for high-speed network connectivity.

Global Autoimmune Disorder Drug Delivery Devices Market 2021-2026 - Home Care Settings Will Dominate due to Longer Wait Times in Hospitals - ResearchAndMarkets.com

Friday, October 15, 2021 - 12:19pm

The outbreak of the COVID-19 pandemic made a relatively positive impact on the Global Autoimmune Disorder Drug Delivery Devices Market.

Key Points: 
  • The outbreak of the COVID-19 pandemic made a relatively positive impact on the Global Autoimmune Disorder Drug Delivery Devices Market.
  • What are the overall market statistics or market estimates (Market Overview, Market Size - By Value, Forecast Numbers, Market Segmentation, Market Shares) of the Global Autoimmune Disorder Drug Delivery Devices Market?
  • What are the key innovations, opportunities, current & future trends, and regulations in the Global Autoimmune Disorder Drug Delivery Devices Market?
  • What are the key results derived from the market surveys conducted during the Global Autoimmune Disorder Drug Delivery Devices Market study?

New ZTE ZPAD 10 Android Tablet Now at TELUS

Friday, October 15, 2021 - 1:00pm

ZTE Canada , a leading global provider of turnkey networking solutions and consumer technology, today announced the new ZPAD 10 tablet will be made available with TELUS .

Key Points: 
  • ZTE Canada , a leading global provider of turnkey networking solutions and consumer technology, today announced the new ZPAD 10 tablet will be made available with TELUS .
  • The ZPAD 10 masters the basics of display, sound, and battery to satisfy your needs.
  • View the full release here: https://www.businesswire.com/news/home/20211015005005/en/
    Get maximum value, connectivity, and quality with the affordable ZTE ZPAD 10 tablet, now available at TELUS.
  • With Wi-Fi and wireless connectivity, the ZPAD 10 tablet doubles as a phone, ensuring you can make and receive video calls wherever you go.

OPSYNVI® (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once Daily Fixed Dose Combination Treatment for Patients with Pulmonary Arterial Hypertension (PAH)

Friday, October 15, 2021 - 12:03pm

Canadians living with PAH, a rare disease for which there is no cure, now have a new treatment option.

Key Points: 
  • Canadians living with PAH, a rare disease for which there is no cure, now have a new treatment option.
  • OPSYNVIshould be used in patients who are currently treated concomitantly with stable doses of macitentan 10mg and tadalafil 40mg (20mg x 2) as separate tablets.
  • If left untreated, PH can lead to right ventricle failure, a serious type of heart failure.
  • As a combination therapy, OPSYNVI conveniently offers two therapies in one daily pill simplifying treatment for patients."

StrongNode Partners with Blockpass for KYC Provision

Friday, October 15, 2021 - 10:00am

HONG KONG, Oct 15, 2021 - (ACN Newswire) - Blockpass and StrongNode are proud to reveal a collaboration that will see StrongNode employ Blockpass' KYC services to ensure customer compliance.

Key Points: 
  • HONG KONG, Oct 15, 2021 - (ACN Newswire) - Blockpass and StrongNode are proud to reveal a collaboration that will see StrongNode employ Blockpass' KYC services to ensure customer compliance.
  • StrongNode IDO is coming up in a little less than two weeks and they are excited to have the BlockPass community and cryptosphere come along on the journey.
  • For businesses and merchants, Blockpass is a comprehensive KYC & AML SaaS that requires no integration and no setup cost.
  • "Compliance and data privacy are two of the pillars of our technology at StrongNode," said Daniel Saito, StrongNode CEO and Co-founder.

Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Infectious Disease R&D Center in Maryland

Friday, October 15, 2021 - 12:00pm

CHATHAM, N.J., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced it will hold a ribbon-cutting ceremony at the Company’s approximately 48,000 square foot research and development center (RDC) in Frederick, Md. on October 18, 2021 at 12:00 p.m. ET. The RDC is expected to support the Company’s expanding infectious disease pipeline. This includes providing internal capacity to discover and develop vaccines and antivirals intended to support U.S. pandemic preparedness.

Key Points: 
  • Senator for Maryland Ben Cardin and U. S. Congressman David Trone representing Marylands 6th Congressional District, are expected to speak at the event.
  • Seth Lederman, M.D., President and Chief Executive Officer of Tonix and Anthony Macaluso, PhD, Executive Vice President, Strategic Development of Tonix will make comments.
  • Marylands economy is an innovation economy, making Tonix and Frederick a great match, said U.S.
  • Tonix Pharmaceuticals does great work in the biopharmaceutical space and, equally important, brings high-paying jobs to our community said Congressman Trone.

Sound Blaster Katana V2: This is the Cutting Edge

Friday, October 15, 2021 - 12:00pm

The Sound Blaster Katana V2 personifies the culmination of Creatives best audio technologies as it brings games and movies to life through its 5.1 channel playback.

Key Points: 
  • The Sound Blaster Katana V2 personifies the culmination of Creatives best audio technologies as it brings games and movies to life through its 5.1 channel playback.
  • The Sound Blaster Katana V2 can be customized to sound and look just the way users like it.
  • All in all, the Sound Blaster Katana V2 provides a complete entertainment experience which transcends beyond what is expected of a gaming soundbar.
  • Aiming at the new mobile networked generation by bridging the worlds of the computer, smartphones, and tablets, Creative continues to reinvent the Sound Blaster, with its ground-breaking Sound Blaster Roar series and USB-audio class of products such as the Sound Blaster X7.

QwikFone Saves The Earth's Rare Elements With Smartphone Refurbishment

Friday, October 15, 2021 - 9:00am

LONDON, Oct. 15, 2021 /PRNewswire/ -- With about 5 billion people using smartphones around the world, the manufacturing volume is increasing every year. To manufacture new smartphones, mining for various precious metals, such as aluminium, copper, lead, and even gold costs our planet pollution in addition to exhausting non-renewable natural resources other than the metal itself.

Key Points: 
  • Refurbished devices by QwikFone are reducing toxic waste generated by old smartphones, tablets, and other tech gadgets.
  • According to Statista.com , each new smartphone consists of about 7% copper, 14% aluminium, and 21% iron.
  • The environmentally aware team at QwikFone recognizes the stigma that comes with used electronics regarding the device's condition and performance.
  • You'll be surprised with how low the prices, and how easy it is to pay for your next eco-friendly smartphone in monthly instalments!